title: Discontinuous LYVE-1 expression in corneal limbal lymphatics: dual function as microvalves and immunological hot spots.
abstract: LYVE-1(+) corneal lymphatics contribute to drainage and immunity. LYVE-1 is widely accepted as the most reliable lymphatic marker because of its continuous expression in lymphatic endothelium. LYVE-1 expression in corneal lymphatics has not been examined. In this study, we report intact CD31(+) corneal lymphatic capillary endothelial cells that do not express LYVE-1. The number of LYVE-1(-) gaps initially increased until 8 wk of age but was significantly reduced in aged mice. C57BL/6 mice showed a notably higher number of the LYVE-1(-)/CD31(+) lymphatic regions than BALB/c mice, which suggests a genetic predisposition for this histological feature. The LYVE-1(-) lymphatic gaps expressed podoplanin and VE-cadherin but not αSMA or FOXC2. Interestingly, the number of LYVE-1(-) gaps in FGF-2, but not VEGF-A, implanted corneas was significantly lower than in untreated corneas. Over 70% of the CD45(+) leukocytes were found in the proximity of the LYVE-1(-) gaps. Using a novel in vivo imaging technique for visualization of leukocyte migration into and out of corneal stroma, we showed reentry of extravasated leukocytes from angiogenic vessels into newly grown corneal lymphatics. This process was inhibited by VE-cadherin blockade. To date, existence of lymphatic valves in cornea is unknown. Electron microscopy showed overlapping lymphatic endothelial ends, reminiscent of microvalves in corneal lymphatics. This work introduces a novel corneal endothelial lymphatic phenotype that lacks LYVE-1. LYVE-1(-) lymphatic endothelium could serve as microvalves, supporting unidirectional flow, as well as immunological hot spots that facilitate reentry of stromal macropahges.
authors.affiliation: Center for Excellence in Functional and Molecular Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
authors.forename: Shintaro
authors.initials: S
authors.lastname: Nakao
authors.forename: Souska
authors.initials: S
authors.lastname: Zandi
authors.forename: Sepideh
authors.initials: S
authors.lastname: Faez
authors.forename: Ri-ichiro
authors.initials: R
authors.lastname: Kohno
authors.forename: Ali
authors.initials: A
authors.lastname: Hafezi-Moghadam
mesh_terms: D000375:Aging / Q000276:immunology / Q000378:metabolism; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D015820:Cadherins / Q000378:metabolism; D003228:Conjunctiva / Q000254:growth & development / Q000276:immunology / Q000378:metabolism; D042783:Endothelial Cells / Q000276:immunology / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism*; D007962:Leukocytes / Q000166:cytology; D016850:Limbus Corneae / Q000254:growth & development / Q000276:immunology / Q000378:metabolism*; D042583:Lymphangiogenesis; D042601:Lymphatic Vessels / Q000378:metabolism; D008297:Male; D026901:Membrane Transport Proteins; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D000099152:Cadherin 5
chemical_list: D015703:Antigens, CD; D015415:Biomarkers; D015820:Cadherins; D006023:Glycoproteins; D026901:Membrane Transport Proteins; D000099152:Cadherin 5; C492273:LYVE1 protein, mouse
references.citation: J Clin Invest. 2005 Nov;115(11):2979-91
references.pmid: 16239969
references.citation: Biochem Biophys Res Commun. 2008 Dec 19;377(3):826-31
references.pmid: 18951870
references.citation: J Cataract Refract Surg. 2003 Apr;29(4):632-3
references.pmid: 12686215
references.citation: J Biol Chem. 2007 Nov 16;282(46):33671-33680
references.pmid: 17884820
references.citation: Annu Rev Pathol. 2008;3:367-97
references.pmid: 18039141
references.citation: FASEB J. 2010 Feb;24(2):504-13
references.pmid: 19858096
references.citation: Am J Hum Genet. 2000 Dec;67(6):1382-8
references.pmid: 11078474
references.citation: FASEB J. 2001 Aug;15(10):1711-7
references.pmid: 11481218
references.citation: J Cell Biol. 1999 Feb 22;144(4):789-801
references.pmid: 10037799
references.citation: J Exp Med. 2007 Oct 1;204(10):2349-62
references.pmid: 17846148
references.citation: Nat Immunol. 2004 Apr;5(4):393-400
references.pmid: 15021878
references.citation: Invest Ophthalmol. 1970 Feb;9(2):146-55
references.pmid: 4905878
references.citation: Nat Med. 2009 Sep;15(9):1023-30
references.pmid: 19668192
references.citation: Exp Eye Res. 2008 Nov;87(5):427-32
references.pmid: 18755186
references.citation: Circ Res. 2004 Jul 23;95(2):204-9
references.pmid: 15192027
references.citation: Genes Dev. 2005 Feb 1;19(3):397-410
references.pmid: 15687262
references.citation: EMBO J. 2002 Apr 2;21(7):1505-13
references.pmid: 11927535
references.citation: Nat Med. 2004 Aug;10(8):813-5
references.pmid: 15235599
references.citation: Nat Med. 2004 Sep;10(9):974-81
references.pmid: 15322537
references.citation: Nat Med. 2007 Dec;13(12):1458-66
references.pmid: 18059280
references.citation: Am J Pathol. 2007 Sep;171(3):1058-65
references.pmid: 17690185
references.citation: Blood. 2011 Jan 20;117(3):1081-90
references.pmid: 20705758
references.citation: Am J Pathol. 1999 Feb;154(2):385-94
references.pmid: 10027397
references.citation: Lancet. 1963 Apr 13;1(7285):832-3
references.pmid: 13979894